(NMDBF) –
-
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
-
NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga
-
NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects
-
NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss
-
NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments
-
NeonMind and BioScript Solutions Announce Strategic Partnership Expanding NeonMind's Specialty Clinic Network for Interventional Psychiatry Treatments
-
NeonMind Appoints Emergency and Addiction Expert Dr. Dinesh Bhayana, as Site Medical Director of its Inaugural Specialty Mental Health Clinic
-
NeonMind to Open its Inaugural Specialty Mental Health Clinic in Mississauga, Ontario
-
NeonMind Appoints Canadian Medical Leader in Anesthesiology, Dr. Daniel Bainbridge, MD, FRCPC to Its Specialty Clinics Advisory Board
-
NeonMind to Present at H.C. Wainwright Bioconnect Conference
-
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
-
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
-
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
-
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
-
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
-
KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
-
NeonMind to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
-
NeonMind Advances Strategy for Specialty Clinic Launch
-
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
-
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
-
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
-
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
-
NeonMind Announces DTC Eligibility
-
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
-
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
-
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
-
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US
-
NeonMind to Webcast Live at Life Sciences Investor Forum on June 24th
-
NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
-
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products
-
NeonMind to Commence Trading on the OTCQB Venture Market
-
Better Plant Announces Agreement with Faire Wholesale Marketplace for Jusu Home and Body Products
-
Better Plant's Jusu Launches Twelve Natural Hair and Body Care Products
-
Better Plant Expands Jusu Juice Home Delivery to Vancouver and Launches New Online Ordering Platform
Back to NMDBF Stock Lookup
